triazoles has been researched along with l 743,872 in 352 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (0.85) | 18.2507 |
2000's | 178 (50.57) | 29.6817 |
2010's | 162 (46.02) | 24.3611 |
2020's | 9 (2.56) | 2.80 |
Authors | Studies |
---|---|
Espinel-Ingroff, A | 1 |
Baquero, F | 1 |
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
Coco, BJ; Kirkpatrick, WR; Patterson, TF; Perea, S | 1 |
Fothergill, AW; Gonzalez, G; Kirkpatrick, WR; Patterson, TF; Perea, S; Rinaldi, MG | 1 |
Chryssanthou, E; Cuenca-Estrella, M | 1 |
Garbino, J; Hirschel, B | 1 |
Bernal, S; Chávez M, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Ramirez, M; Serrano, Mdel C; Valverde-Conde, A | 1 |
Chan, J | 1 |
Lipp, HP | 1 |
Holzgrabe, U; Schäfer-Korting, M | 1 |
Alangaden, GJ; Chandrasekar, PH; Manavathu, EK | 1 |
Feldmesser, M; Pamer, EG; Van Epps, HL | 1 |
Sutton, DA | 1 |
Ullmann, AJ | 1 |
Girmenia, C; Martino, P | 1 |
Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ | 1 |
Schäfer-Korting, M | 1 |
Gupta, AK; Tomas, E | 1 |
Giles, SS; Kurtzberg, J; Perfect, JR; Schell, WA; Steinbach, WJ; Trinh, JV | 1 |
Bliss, JM; Gigliotti, F; Wellington, M | 1 |
Sims-McCallum, RP | 1 |
Bilger, K; D'incan, E; Damaj, G; Doglio, MF; Faucher, C; Gastaut, JA; Ivanov, V; Le Brigand, B; Vey, N | 1 |
Martin, PL; Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ | 1 |
Espinel-Ingroff, A; Holliday, N; Killian, SB; Knapp, CC; Messer, SA; Pfaller, M | 1 |
Cappelli, B; Castagnola, E; Dodero, P; Faraci, M; Machetti, M; Molinari, AC; Morreale, G; Tomà, P | 1 |
Dupont, B | 1 |
Mehta, J; Trifilio, S; Verma, A; Williams, S; Zembower, T | 1 |
Schwartz, S; Thiel, E | 1 |
Höhl, R | 1 |
Blankenship, JR; Heitman, J; Onyewu, C; Perfect, JR; Schell, WA; Steinbach, WJ | 1 |
Rubin, ZA; Somani, J | 1 |
Alaggio, R; Calore, E; Cesaro, S; Cusinato, R; Messina, C; Pillon, M; Toffolutti, T; Zanesco, L | 1 |
Friedrich, W; Gahr, M; Hahn, G; Koch, A; Roesler, J; Rösen-Wolff, A | 1 |
Antoniades, A; Giotakis, J; Imbrios, G; Manesis, EK; Tsiodras, S; Zafiropoulou, R | 1 |
Germaud, P; Morin, O | 1 |
Gil-Lamaignere, C; Müller, FM; Zhu, LP | 1 |
Blin, N; Gaillard, F; Harousseau, JL; Milpied, N; Moreau, P; Morin, O; Morineau, N | 1 |
Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE | 1 |
Gavaldá, J; Lumbreras, C | 1 |
Klastersky, J | 1 |
Boeckh, M; Carter, RA; Corey, L; Kim, HW; Marr, KA | 1 |
Viscoli, C | 1 |
D'Antonio, D; Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I | 1 |
Alangaden, GJ; Chandrasekar, PH; Cutright, JL; Ganesan, LT; Manavathu, EK | 1 |
Benjamin, DK; Heitman, J; Miller, JL; Perfect, JR; Schell, WA; Singh, N; Steinbach, WJ | 1 |
Perfect, JR | 2 |
Marr, K | 1 |
Breit, SM; Grand, MG; Hariprasad, SM; Mieler, WF; Mills, MD; Shah, GK | 1 |
Bareau, B; Camus, C; Tattevin, P | 1 |
Danaher, PJ | 1 |
Lowry, CM; Marty, FM | 1 |
Balwierz, W | 1 |
Belohradsky, BH; Führer, M; Graubner, UB; Kammer, B; Moelter, C; Schmid, I; Schuster, F | 1 |
Alcazar-Fuoli, L; Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
Bailly, E; Bastides, F; Ehrmann, S; Gissot, V; Legras, A; Magro, P; Mercier, E | 1 |
Dinser, R; Grgic, A; Kim, YJ; Pfreundschuh, M; Schubert, J | 1 |
Cesaro, S; Visintin, G | 1 |
Ermert, L; Lohmeyer, J; Lommel, D; Ludwig, M; Schneider, H; Sziegoleit, A; Weidner, W | 1 |
Gil-Lamaignere, C; Hess, R; Heyn, K; Kappe, R; Müller, FM; Salvenmoser, S | 1 |
Christmann, D; Eisenmann, B; Forestier, E; Hansman, Y; Lesens, O; Martinot, M; Remy, V | 1 |
Böhme, A; Haas, A; Maschmeyer, G | 1 |
Steinbach, WJ | 2 |
Kofla, G; Ruhnke, M | 1 |
Coco, BJ; Fothergill, AW; Kirkpatrick, WR; Oliveira, ER; Patterson, TF; Redding, SW | 1 |
Benjamin, DK; Steinbach, WJ; Zaoutis, TE | 1 |
MacCallum, DM; Odds, FC; Whyte, JA | 1 |
Azar, DT; D'Amico, DJ; Durand, ML; Kieval, SJ; Kim, IK; Loewenstein, JI; Lujan, BJ; Martin, SS; Miller, FS; Miller, JW; Tobin, EH | 1 |
Costa-de-Oliveira, S; Espinel-Ingroff, A; Pina-Vaz, C; Rodrigues, AG | 1 |
Bergeron, A; Dromer, F; Ferry, C; Feuilhade, M; Gluckman, E; Hermoso, DG; Lacroix, C; Molina, JM; Pavie, J; Ribaud, P; Robin, M | 1 |
Bauer, M; Graninger, W; Joukhadar, C; Kulemann, V | 1 |
Bonatti, H; Dierich, MP; Freund, M; Gastl, G; Griff, K; Kropshofer, G; Lass-Flörl, C; Mayr, A; Nachbaur, D; Petzer, A | 1 |
Baker, CJ; Pannaraj, PS; Walsh, TJ | 1 |
Colombo, GL; Morlotti, L; Serra, G | 1 |
Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D | 1 |
Conte, JV; Dropulic, LK; Girgis, R; Mcdyer, JF; Orens, JB; Shlobin, OA; Yang, SY | 1 |
Barfield, RC; Behm, FG; Burnette, K; Eldridge, P; Hale, GA; Handgretinger, R; Knapp, K | 1 |
Clemons, KV; Espiritu, M; Parmar, R; Stevens, DA | 1 |
Carpenter, J; Howell, A; Hurley, D; Midturi, J; Sierra-Hoffman, M; Winn, R | 1 |
Chang, SC; Chen, YC; Hsieh, SM; Lee, HT; Pan, SC | 1 |
Marik, PE; Raman, T | 1 |
Aguado, JM; Del Busto, R; Fisher, RA; Forrest, G; Houston, S; Husain, S; Klintmalm, GB; Kontoyiannis, DP; Lewis, RE; Limaye, AP; Miller, R; Montoya, JG; Muñoz, P; Patton, P; Pursell, K; Rosso, F; Safdar, N; Singh, N; Wagener, MM | 1 |
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
Casadevall, A; Martinez, LR | 1 |
Castro-Orjales, MJ; Collell-Llach, MD; de la Torre-Fernández, MJ; Díaz-López, MD; León, C; López-Ciudad, V; Pérez de Juan-Romero, MA; Sanz-Rodríguez, C | 1 |
Bosch, M; Cantón, E; de Llanos, R; Jarque, I; Molina, A; Pemán, J; Salavert, M | 1 |
Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL | 1 |
Brandenburg, VM; Floege, J; Guetgemann, A; Ketteler, M; Riehl, J | 1 |
Cacciapuoti, A; Halpern, J; Loebenberg, D; Mendrick, C; Norris, C; Patel, R | 1 |
Bäsecke, J; Glass, B; Perske, C; Rüchel, R | 1 |
Björkholm, M; Cherif, H; Kalin, M | 1 |
Burhenne, J; Cornely, OA; Elter, T; Fätkenheuer, G; Gossmann, A; Kuchta, J; Riedel, KD; Schröder, U; Seifert, H; Sieniawski, M; Wickenhauser, C | 1 |
Gottfredsson, M; Steingrímsdóttir, H | 1 |
Kadota, J; Tokimatsu, I | 1 |
Bodkin, J; Bubb, WA; Coen, M; Himmelreich, U; Kuchel, PW; Power, D; Sorrell, TC | 1 |
Aperis, G; Mylonakis, E; Spanakis, EK | 1 |
Edwards, JE; Ibrahim, A; Reed, C; Spellberg, B; Walot, I | 1 |
Manfredi, R; Sabbatani, S | 1 |
Chang, SC; Diekema, DJ; Erzsebet, P; Gibbs, DL; Kibbler, C; Mendez, M; Newell, VA; Pfaller, MA | 1 |
Denning, DW; Gardiner, RE; Howard, SJ; Moore, CB; Park, S; Perlin, DS; Webster, I | 1 |
Demchok, JP; Meletiadis, J; O'Shaughnessy, EM; Stergiopoulou, T; Walsh, TJ | 1 |
Denning, DW; Heep, M; Mosquera, J; Schmitt-Hoffmann, A; Sharp, A; Spickermann, J; Warn, PA | 1 |
Patel, R; Piper, KE; Shuford, JA; Steckelberg, JM | 1 |
Araujo, R; Pina-Vaz, C; Rodrigues, AG | 1 |
Campbell, C; Johnson, E; Lamagni, TL; Pezzoli, L | 1 |
Canton, E; Espinel-Ingroff, A; Gibbs, D; Wang, A | 1 |
Benjamin, DK; Cotten, CM; Perfect, JR; Schell, WA; Smith, PB; Steinbach, WJ; Walsh, TJ | 1 |
Del Castillo, A; Díaz, S; Domínguez-Gil, A; García Vargas, M; Martín, I; Sánchez, C | 1 |
Avci, B; Cetinkaya, Z; Ermis, SS; Inan, UU; Kusbeci, T; Ozturk, F; Yavas, G | 1 |
Meletiadis, J; O'Shaughnessy, EM; Peter, J; Stergiopoulou, T; Walsh, TJ | 1 |
Arthington-Skaggs, B; Ellis, D; Espinel-Ingroff, A; Fothergill, A; Gibbs, DL; Iqbal, N; Messer, S; Pfaller, MA; Rinaldi, M; Wang, A | 1 |
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
Bonatti, H; Lass-Floerl, C; Lechner, M; Lorenz, I; Piza, H; Rieder, J; Rieger, M | 1 |
Aoun, N; Baixench, MT; Bretagne, S; Dannaoui, E; Desnos-Ollivier, M; Garcia-Hermoso, D; Piketty, C; Ramires, S | 1 |
Alonso, N; Bajo, R; Casado, MS; de la Llana, FG; Fajardo, M; Garcia-Dominguez, M; Sanz-Rodriguez, C; Vagace, JM; Zarallo, L | 1 |
Fincher, T; Fulcher, SF | 1 |
Eichhorn, ME; Hartl, WH; Jauch, KW; Joka, M; Küchenhoff, H; Wolf, H | 1 |
Ament, AJ; de Groot, R; Donnelly, JP; Hübben, MW; Severens, JL; van 't Wout, J; Verweij, PE; Warris, A | 1 |
Acharya, NR; Chidambaram, JD; Fothergill, AW; Hong, KC; Lalitha, P; Lietman, TM; Maxey, KJ; McLeod, SD; Prajna, NV; Ruiz, J; Shapiro, BL; Srinivasan, M | 1 |
Alioua, D; Anract, P; Dougados, M; Dupont, B; Guerini, H; Guignard, S; Hubert, D; Paugam, A | 1 |
Bouza, E; Guembe, M; Guinea, J; Peláez, T; Torres-Narbona, M | 1 |
Maida, CM; Milici, ME; Oliveri, S | 1 |
Braverman, RM; Davis, CM; Dishop, MK; Noroski, LM; Paul, ME; Rosenblatt, HM; Sutton, DA | 1 |
Cantón, E; Chirivella, M; Crespo, M; Frasquet, J; Gobernado, M; Ortiz, R; Osseyran, F; Pemán, J; Pérez-Bellés, C; Quesada, A | 1 |
Eschertzhuber, S; Hoefer, D; Hoermann, C; Lass-Florl, C; Velik-Salchner, C | 1 |
Deising, HB; Serfling, A; Wohlrab, J | 1 |
Aydin, S; Ertugrul, B; Gultekin, B; Kir, E; Uyar, G | 1 |
Gubler, C; Imhof, A; Müllhaupt, B; Schneemann, M; Wildi, SM | 1 |
Gleissner, B; Mansmann, V; Schilling, A; Seibold, M | 1 |
Cesur, S; Kaynak, F; Ozçelik, B; Sipahi, B; Sultan, N | 1 |
Beckius, ML; Borra, H; Griffith, ME; Hawley, JS; Hospenthal, DR; McCall, S; Moon, JE; Murray, CK; Ressner, RA; Rivard, RG | 1 |
Caira, M; Fianchi, L; Maviglia, R; Montini, L; Pagano, L; Posteraro, B; Voso, MT | 1 |
Kontoyiannis, D | 1 |
Gahn, B; Gramatzki, M; Repp, R; Schub, N | 1 |
Bergeron, A; de Latour, RP; Devergie, A; Ferry, C; Ghannoum, M; Gluckmana, E; Lacroix, C; Lapalu, J; Madureira, A; Ribaud, P; Robin, M; Rocha, V; Socié, G | 1 |
Stratakos, G; Zakynthinos, S | 1 |
Barchiesi, F; Maida, CM; Milici, ME; Scalise, G; Spreghini, E | 1 |
Carrillo-Muñoz, AJ; Casals, JB; del Valle, O; Estivill, MD; Ezkurra, PA; Giusiano, G; Quindós, G; Santos, P | 1 |
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
Arthington-Skaggs, BA; Chaturvedi, V; Ghannoum, MA; Holliday, N; Iqbal, NJ; Killian, SB; Knapp, C; Messer, SA; Ostrosky-Zeichner, L; Pfaller, MA; Ramani, R; Rex, JH; Sein, T; Vazquez, JA; Walsh, TJ | 1 |
Bou, G; Fernández, A; Lueiro, F; Velasco, D | 1 |
Chirch, L; Fuhrer, J; Roche, P | 1 |
Can, MF; Cetiner, S; Gorenek, L; Ozerhan, I; Tozkoparan, E; Yagci, G | 1 |
Begueret, H; Beylot-Barry, M; Couprie, B; Domergue, V; Doutre, MS; Huerre, M; Orlandini, V; Tunon de Lara, M | 1 |
Datry, A; Delabesse, E; Dhédin, N; Etienne, A; Gaspar, N; Lmimouni, B; Morel, V; Vernant, JP | 1 |
Alanio, A; Baruchel, A; Brethon, B; de Kerviler, E; Feuilhade de Chauvin, M; Lacroix, C; Leblanc, T; Menotti, J | 1 |
Chu, CC; Hsueh, PR; Ruan, SY | 1 |
Mavinkurve-Groothuis, AM; van Die, LE; van't Hek, LG; Verweij, PE; Warris, A; Zwitserloot, AM | 1 |
Lahat, Y; Sandovsky-Losica, H; Segal, E; Shwartzman, R | 1 |
Kulpraneet, M; Panichchob, P; Prayongratana, K; Tantisiriwat, W | 1 |
Benesch, M; Dornbusch, HJ; Lackner, H; Schwinger, W; Sovinz, P; Strenger, V; Urban, C | 1 |
Ayala, J; Elizondo, M; González, GM | 1 |
Mircus, G; Osherov, N; Shadkchan, Y; Shalit, I | 1 |
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L | 1 |
Bouadma, L; Da Silva, D; Massias, L; Nataf, P; Papy, E; Ruiz, S; Wolff, M | 1 |
Alves, AF; Anjos, J; de Hoog, GS; Estevão, H; Faria, E; Gonçalves, T; Hipolito, E; Morais, PV | 1 |
Jones, B; Lang, S; McCulloch, E; Mowat, E; Ramage, G; Williams, C | 1 |
Brown, TA; Grooters, AM; Hosgood, GL | 1 |
Niki, Y | 1 |
Tu, EY | 1 |
Enache-Angoulvant, A; Girard, A; Hennequin, C; Poirot, JL | 1 |
Annaert, P; Hermans, G; Meersseman, P; Meersseman, W; Spriet, I; Verbesselt, R; Willems, L | 1 |
Chemaissani, A; Ernestus, K; Kamp, M; Knüttgen, D; Matten, J; Sakka, SG; Ströhlein, M; Wappler, F | 1 |
Fanci, R | 1 |
Graninger, W; Kratzer, C; Lassnigg, A; Presterl, E; Tobudic, S | 2 |
Ayats, J; Fernández, N; Gasch, O; Santin, M | 1 |
Aşik, G; Ayçiçek, A; Cetinkaya, Z; Kenar, F; Kiraz, N; Kiyici, H | 1 |
Baggen, L; Chisholm, J; Sharland, M; Thomas, L | 1 |
Pérez, P; Piñar, D; Quiles, JA; Reus, S | 1 |
Castel, V; Gonzalez-Esteban, J; Madero, L; Sanchez de Toledo, J; Sanz-Rodriguez, C; Sevilla, J | 1 |
Berger, N; Bonatti, H; Geltner, C; Grif, K; Lass-Flörl, C; Lechner, M; Margreiter, R; Stelzmueller, I | 1 |
Angerer, K; Bonatti, H; Geltner, C; Lass-Floerl, C; Lechner, M; Schmid, T; Singh, N; Singh, R; Stelzmueller, I | 1 |
Barozzi, P; Forghieri, F; Luppi, M; Messino, M; Morselli, M; Pecorari, M; Potenza, L; Rossi, G; Rumpianesi, F; Torelli, G; Vallerini, D | 1 |
Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL | 1 |
Eberhardt, R; Ebinger, D; Eckerle, I; Eisenbach, C; Gotthardt, D; Junghanss, T; Schnabel, PA; Stremmel, W | 1 |
Delaere, L; Lagrou, K; Maertens, J; Peetermans, WE; Spriet, I; Willems, L | 1 |
Amorim, CS; Briones, MR; Colombo, AL; Gonçalves, SS; Melo, AS; Nucci, M; Padovan, AC | 1 |
Groll, AH; Tragiannidis, A | 1 |
Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A | 1 |
Ali, R; Altundal, Y; Ener, B; Hakyemez, B; Kocaeli, H; Ozçelik, T; Ozkalemkaş, F; Ozkocaman, V; Tunali, A | 1 |
Boikov, D; Nagappan, V; Vazquez, JA | 1 |
Aloisi, T; Aversa, F; Bonini, A; Caira, M; Candoni, A; Caramatti, C; Cattaneo, C; Chierichini, A; de Waure, C; Fadda, RM; Fanci, R; Ferrara, F; Fianchi, L; Invernizzi, R; Leone, G; Luppi, M; Martino, B; Melillo, L; Mitra, ME; Nosari, A; Offidani, M; Pagano, L; Pastore, D; Picardi, M; Potenza, L; Riva, M; Rossini, F; Specchia, G; Stanzani, M; Vacca, A | 1 |
Capote, M; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rojas, R; Sánchez-García, J; Serrano, J; Tabares, S; Torres, A | 1 |
Al-Abdely, HM; Al-Tawfiq, JA | 1 |
Akin, M; Ay, Y; Balkan, C; Karapinar, B; Kavakli, K; Yilmaz, D | 1 |
Christen, S; Egger, SS; Gratwohl, A; Haschke, M; Krähenbühl, S; Leu, C; Meier, S | 1 |
Alvarez, M; Attal, M; Cassaing, S; Chabrol, A; Cuzin, L; Giron, J; Huguet, F; Linas, MD; Récher, C; Tetu, L; Verdeil, X | 1 |
Cornely, OA; Rüping, MJ; Vehreschild, JJ | 1 |
Bakker-Woudenberg, IA; Tavakol, M; van de Sande, WW; van Vianen, W | 1 |
Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ | 1 |
Corradini, N; Dannaoui, E; Gay-Andrieu, F; Hoinard, D; Lortholary, O; Méchinaud, F; Roux, BG | 1 |
Georgiadou, E; Roilides, E; Simitsopoulou, M; Walsh, TJ | 1 |
Begué, D; Billaud, E; Boussaud, V; Caruba, T; Guillemain, R; Korb, V; Prognon, P; Sabatier, B; Thomas, A | 1 |
Dag, I; Kasifoglu, N; Kiraz, N; Kiremitci, A; Oz, Y; Yamac, M | 1 |
Li, H; Lu, Q; Wan, Z; Zhang, J | 1 |
Bouchara, JP; Danner-Boucher, I; Despins, P; Gay-Andrieu, F; Haloun, A; Horeau-Langlard, D; Jossic, F; Le Pape, P; Miegeville, M; Morio, F; Nourry, L; Pattier, S; Talarmin, JP; Treilhaud, M | 1 |
Jensen, SG; Nielsen, TL | 1 |
Corey, M | 1 |
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA | 1 |
Beresford, E; Krishna, G; Ma, L; Medlock, M; Noren, C; Power, E; Vickery, D; Yu, X | 1 |
Kim, A; Kuti, JL; Nicolau, DP | 1 |
Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS | 1 |
Andreesen, R; Beier, F; Hildebrandt, GC; Holler, E; Holzmann, T; Kittan, N; Schardt, K | 1 |
Cisneros-Lanuza, A; Díaz-Llopis, M; Duch-Samper, A; Hurtado-Sarrió, M; Peman-Garcíia, J; Vazquez-Polo, A | 1 |
Dalpke, A; Müller, FM; Salvenmoser, S; Seidler, MJ | 1 |
Aversa, F; Caira, M; Candoni, A; Leone, G; Luppi, M; Martino, B; Nosari, A; Offidani, M; Pagano, L; Specchia, G; Tosti, ME; Valentini, CG | 1 |
Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A | 1 |
Belda, S; Cremades, R; Lopez, P; Rodriguez, JC; Royo, G; Ruiz-Garcia, M; Soler, L | 1 |
Ehlert, K; Fegeler, W; Groll, AH; Kerl, K; Koch, B; Rossig, C | 1 |
Atalay, H; Erekul, S; Nar, A; Ozbek, O; Solak, Y; Turk, S; Turkmen, K | 1 |
Cai, B; Chen, H; Li, G; Li, H; Liu, W; You, C | 1 |
Guarro, J; Mayayo, E; Pastor, FJ; Pujol, I; Ruíz-Cendoya, M; Sutton, DA | 1 |
Bello, I; Golmia, R; Hamerschlak, N; Marra, A; Osawa, A; Scheinberg, M | 1 |
Bille, J; Calandra, T; Decosterd, LA; Marchetti, O; Mercier, T; Pesse, B; Rochat, B; Tissot, F; Widmer, N; Zanolari, B | 1 |
Huang, Y; Li, HY; Liu, L; Wang, GY; Xia, ZF; Zhang, JR; Zhu, SH | 1 |
Chen, DM; Guo, LN; Liu, Y; Lü, HX; Shi, JY; Shi, Y; Wang, H; Xi, LY; Xu, YC; Zhao, WS; Zhou, X | 1 |
Coorevits, L; Jeurissen, A; Lagrou, K; Schuermans, C; Surmont, I; van Bergen, M; Verhaegen, J | 1 |
Falcone, M; Massetti, AP; Russo, A; Venditti, M; Vullo, V | 1 |
Ayuk, FA; Dahlke, J; Kröger, N; Lellek, H; Waldenmaier, D; Wolschke, C; Zander, AR | 1 |
Ko, KS; Lee, JY; Peck, KR; Song, JH | 1 |
Abbes, S; Ayadi, A; Ben Jemaa, M; Bouaziz, M; Cheikhrouhou, F; Chelly, H; Hammami, B; Khaled, S; Makni, F; Néji, S; Sellami, A; Sellami, H | 1 |
Kuithan, F; Scheer, F; Wiggermann, P | 1 |
Blanche, S; Bougnoux, ME; Catherinot, E; Coignard, H; Debourgogne, A; Garcia-Hermoso, D; Hassouni, N; Lecuit, M; Lortholary, O; Machouart, M; Rivier, A; Salmon, A | 1 |
Andes, D; Bastulli, C; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Iqbal, N; Knapp, C; Lockhart, SR; Marchillo, K; Messer, S; Ostrosky-Zeichner, L; Paetznick, VL; Pfaller, MA; Ramani, R; Rodriguez, J; Sein, T; Walsh, TJ; Welshenbaugh, AR | 1 |
Dag, I; Kiraz, N; Oz, Y | 2 |
Öncü, S | 1 |
Gurgle, HE; Oinonen, MJ; Pakyz, AL | 1 |
Antachopoulos, C; Chatzimoschou, A; Georgiadou, E; Katragkou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ | 1 |
Ananda-Rajah, MR; Cheng, A; Dooley, M; Morrissey, CO; Neville, AM; Slavin, M; Spelman, T | 1 |
Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC | 1 |
Ruiz-Camps, I | 1 |
Diekema, DJ; Ledeboer, NA; Peterson, JF; Pfaller, MA; Riebe, KM; Rinaldi, MG | 1 |
Karthaus, M | 1 |
Kong, DC; Leung, L; Neoh, CF; Stewart, K; Vajpayee, RB | 1 |
Angoulvant, A; Epaud, R; Le Pointe, HD; Levine, E; Petit, A | 1 |
Clemons, KV; Schwartz, JA; Stevens, DA | 2 |
Garcia-Hermoso, D; Gay-Andrieu, F; Haloun, A; Le Pape, P; Leclair, F; Lepoivre, T; Miegeville, M; Miossec, C; Morio, F; Treilhaud, M | 1 |
Ilkit, M; Kiraz, N; Oz, Y; Ozdemir, HG | 1 |
Bhagwat, K; Brooks, M; Eisen, D; Royse, A; Royse, C; Sparks, P | 1 |
Castanheira, M; Hata, K; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA | 1 |
Barbui, A; Busca, A; De Rosa, FG; Falda, M; Limerutti, G; Locatelli, F | 1 |
Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
Lingegowda, PB; Tan, AL; Tan, BH; Tan, CK | 1 |
Björkholm, M; Celsing, F; Grane, P; Kalin, M | 1 |
Al-Badriyeh, D; Kong, DC; Liew, D; Stewart, K | 1 |
Banerjee, R; Dhiman, N; Henry, NK; Huskins, WC; Joshi, AY; Santillan Salas, CF; Wengenack, NL | 1 |
Castanheira, M; Duncanson, F; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA | 1 |
Bassetti, M; Molinari, MP; Mussap, M; Nicco, E; Taramasso, L; Viscoli, C | 1 |
Jones, B; Kirkpatrick, WR; Lappin, DF; McCulloch, E; Patterson, TF; Rajendran, R; Ramage, G; Shrief, R; Warn, P; Williams, C | 1 |
Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M | 1 |
Al-Saigh, R; Meletiadis, J; Roilides, E; Velegraki, A; Walsh, TJ; Zerva, L | 1 |
Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA | 1 |
Bouza, E; Giannella, M; Guinea, J; Klaassen, CH; Muñoz, P; Peláez, T; Valerio, M | 1 |
Campos-Herrero, MI; Horcajada, I; Medina-Rivero, F; Tandón, L | 1 |
Shen, YF; Sun, HL; Zhou, X | 1 |
Arancia, S; Arruda, DC; Ciociola, T; Conti, S; D'Adda, T; De Bernardis, F; Gabrielli, E; Galati, S; Magliani, W; Pericolini, E; Pertinhez, TA; Pinto, MR; Polonelli, L; Spisni, A; Travassos, LR; Vecchiarelli, A; Zanello, PP | 1 |
Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M | 1 |
Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC | 1 |
Egerer, G | 1 |
Bai, C; Chen, B; Huang, HD; Huang, Y; Li, Q; Wang, Q; Wu, N; Yao, XP | 1 |
Baghaei, P; Droudinia, A; Javanmard, P; Mansouri, D; Marjani, M; Najafizadeh, K; Sarrafzadeh, SA; Soraghi, A; Tabarsi, P; Zandian, P | 1 |
Chen, TC; Chen, YC; Chen, YH; Lu, PL | 1 |
Chen, Z; Wei, J; Yang, Q | 1 |
Andes, DR; Baddley, JW; Boeckh, M; Brizendine, KD; Chiller, T; Ito, JI; Kauffman, CA; Kontoyiannis, DP; Lyon, GM; Marr, KA; Oster, RA; Pappas, PG; Patterson, TF; Schuster, MG | 1 |
Brilhante, RS; Caetano, ÉP; Camargo, ZP; Castelo-Branco, DS; Cordeiro, RA; Fechine, MA; Lima, RA; Mesquita, JR; Monteiro, AJ; Pereira, JF; Rocha, MF; Sidrim, JJ | 1 |
Dag, I; Kiraz, N; Kiremitci, A; Metintas, S; Oz, Y | 1 |
Maack, KH; Tarp, B | 1 |
Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L | 1 |
Berghs, HAM; Carvalho, LR; Kacew, S; Martins, MA; Melhem, MSC; Mendes, RP; Moris, DV; Pimenta-Rodrigues, MV; Souza, LR; Szeszs, MW | 1 |
Curtis, LT | 1 |
de Souza Bonfim-Mendonça, P; Fiorini, A; Godoy, JS; Nakamura, SS; Pieralisi, N; Shinobu-Mesquita, C; Svidzinski, TI; Yamada, SS | 1 |
Buendía, B; Cuenca-Estrella, M; De La Camara, R; Mellado, E; Rodriguez-Tudela, JL | 1 |
Chen, W; Li, L; Li, R; Liu, W; Sun, Y; Wan, Z | 1 |
Chauhan, NM; Karuppayil, SM; Raut, JS; Shinde, RB | 1 |
Denes, E; Dupon, M; Fiorenza, F; Megherbi, M; Saint-Marcoux, F; Weinbreck, P | 1 |
Brisou, P; Darles, C; Gaillard, T; Pons, S; Roméo, E | 1 |
Buer, J; Dittmer, S; Hamprecht, A; Lackner, M; Rath, PM; Schemuth, H; Sedlacek, L; Steinmann, E; Steinmann, J | 1 |
Brilhante, RS; Caetano, EP; Camargo, ZP; Castelo Branco, DS; Cordeiro, RA; Fechine, MA; Lima, DT; Lima, RA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Rocha, MF; Sidrim, JJ | 1 |
Yoshida, M | 1 |
Shi, Y; Sun, HM; Xu, XY; Zhao, BL | 1 |
Badali, H; Curfs-Breuker, I; de Hoog, GS; Deng, S; Liao, W; Meis, JF; Najafzadeh, MJ; Pan, B; Yang, L | 1 |
Jones, B; Jose, A; Lappin, DF; Ramage, G; Sherry, L; Williams, C | 1 |
Levy, ER; McCarty, JM; Shane, AL; Weintrub, PS | 1 |
Galgiani, JN | 1 |
Averette, AF; Chen, YL; Heitman, J; Lehman, VN; Perfect, JR | 1 |
Li, R; Yu, J; Zhang, S | 1 |
Arıkan Akdağlı, S; Aydeniz Ozansoy, F; Dursunoğlu, N; Ergin, C; Kutlu, M; Sarı, I; Sarıbaş, Z | 1 |
Hatipoglu, H; Hatipoglu, N | 1 |
Andes, DR; Lepak, AJ; Marchillo, K; VanHecker, J | 1 |
Aline-Fardin, A; Buot, G; Dannaoui, E; Degulys, A; Guitard, J; Hennequin, C; Lapusan, S; Marie, JP; Rio, B | 1 |
Boral, OB; Cağatay, P; Keçeli, SA; Sonmez, N; Tamer, GS; Willke, A | 1 |
Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA | 1 |
Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF | 1 |
Atalay, MA; Copur Çiçek, A; Kasap Tekinşen, FF; Kaynar, L; Koç, AN; Sav, H | 1 |
Balci, I; Eksi, F; Gayyurhan, ED | 1 |
Chen, F; Shi, Y; Su, X; Sun, WK; Xu, XY; Zhang, M | 1 |
Ascioglu, S; Chan, KA | 1 |
Kunicka-Styczyńska, A; Maroszyńska, I; Maroszyńska, M; Rajkowska, K | 1 |
Aslan, SO; Dizbay, M; Fidan, I; Kalkanci, A; Ogan, MC; Sahin, N; Yesilyurt, E | 1 |
Jackson, TL; Rodrigues, IA | 1 |
Bandeira, TJPG; Brilhante, RSN; Cordeiro, RA; Macedo, RB; Marques, FJF; Moreira, JLB; Rocha, MFG; Sidrim, JJC; Teixeira, CEC | 1 |
Berg, T; Brandmaier, P; Jonas, S; Lübbert, C; Mohr, FW; Pfeiffer, D; Rodloff, A; Schmelzle, M; Schubert, S; Wiltberger, G | 1 |
Albert, ND; Kontoyiannis, DP; Lewis, RE | 1 |
Mavridou, E; Meletiadis, J; Mouton, JW; Rijs, A; Verweij, PE | 1 |
Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R | 1 |
Li, R; Wan, Z; Yao, L; Yu, J | 1 |
Bulanda, M; Jagielski, T; Skóra, M | 1 |
Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF | 1 |
Arilla, MJ; Boluda, B; Calvillo, P; Cano, I; Carpio, N; Jarque, I; Lancharro, A; López-Chuliá, F; Lorenzo, I; Martínez, J; Martínez-Cuadrón, D; Montesinos, P; Navarro, I; Pemán, J; Rodríguez-Veiga, R; Salavert, M; Sanz, GF; Sanz, J; Sanz, MA | 1 |
Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF | 1 |
Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S | 1 |
Badali, H; Dolatabadi, S; Fakhim, H; Mirhendi, H; Nabili, M; Poorzad, N; Vaezi, A; Zarei, F | 1 |
Hall, RG; Payne, KD | 1 |
Aala, F; Amirizad, K; Aslani, N; Badali, H; Hashemi, SJ; Khodavaisy, S; Nazeri, M; Nouripour-Sisakht, S; Rezaie, S; Sorkherizi, MS | 1 |
Ding, X; Gao, L; Liu, Z; Sun, Y; Wu, Q; Zeng, T | 1 |
Lanternier, FL; Lortholary, O; Pilmis, B | 1 |
Arslan, U; Dagi, HT; Findik, D; Senkeles, C | 1 |
Legendre, DP; Muzny, CA; Riley, TT; Swiatlo, E | 1 |
Chung, SJ; Hwang, WY; Tan, AL; Tan, BH; Tan, TT; Thien, SY | 1 |
Ahmed, SA; Behrens-Baumann, W; de Hoog, GS; Harak, H; Hofmüller, W; Seibold, M; Tammer, I; van Diepeningen, AD | 1 |
Banjara, N; Florescu, DF; Gomes-Neto, JC; Hallen-Adams, HE; Iwen, PC; Mercer, DF; Suhr, MJ | 1 |
Birch, M; Law, D; Wiederhold, NP | 1 |
Arthur, I; Baird, R; Bak, N; Blyth, C; Botes, J; Chapman, B; Chen, S; Cheong, E; Cooley, L; George, CR; Goeman, E; Hajkowicz, K; Halliday, C; Heath, CH; Hofmeyr, A; Kalukottege, P; Keighley, C; Kennedy, K; Kesson, A; Kidd, S; Korman, TM; Leung, M; Liu, E; Macesic, N; Marriott, D; McMullan, B; Morrissey, CO; Pendle, S; Robson, J; Slavin, M; Sorrell, TC; Underwood, N; van Hal, S; Weeks, K | 1 |
Bader, O; Baretton, G; Buchheidt, D; Geibel, S; Groß, U; Jacobs, E; Ostrosky-Zeichner, L; Rößler, S; Sommer, U; Spiess, B; Stölzel, F | 1 |
Badali, H; Chowdhary, A; Dannaoui, E; Fakhim, H; Meis, JF; Prakash, A; Vaezi, A | 1 |
Badali, H; Badiee, P; Boekhout, T; Diba, K; Hossaini Nasab, A; Jafarian, H; Mirhendi, H; Moghadam, AG; Mohammadi, R; Najafzadeh, MJ; Shamsizadeh, A; Soltani, J | 1 |
Ahangarkani, F; Aslani, N; Badali, H; Boekhout, T; Hagen, F; Kolecka, A; Meis, JF; Meyabadi, MF; Shokohi, T | 1 |
El-Najjar, N; Gessner, A; Hösl, J | 1 |
Andersen, LO; Arendrup, MC; Hare, RK; Irga-Jaworska, N; Jaworski, R; Jensen, HE; Malecka, A; Nielsen, HV; Pomorska, A; Radon-Proskura, J | 1 |
Andes, D | 1 |
Chetchotisakd, P; Croos-Dabrera, R; De Waele, J; Engelhardt, M; Fredericks, C; Herbrecht, R; Jaruratanasirikul, S; Kovanda, L; Kullberg, BJ; Lademacher, C; Ostrosky-Zeichner, L; Pappas, PG; Rahav, G; Rotstein, C; Sobel, JD; Thompson, GR; Van Wijngaerden, E; Vazquez, J; Viscoli, C | 1 |
Lehrnbecher, T; Schmidt, S; Schubert, R; Tramsen, L | 1 |
Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E | 1 |
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
Erbaş, G; Kalkanci, A; Köktürk, N; Özkurt, ZN; Pepeler, MS; Tunçcan, ÖG; Yegin, ZA; Yildirim, Z; Yildiz, Ş | 1 |
Gharaghani, M; Taghipour, S; Zarei Mahmoudabadi, A | 1 |
Alexander, S; Chen, L; Dang, H; Dvorak, CC; Esbenshade, AJ; Fisher, BT; Nieder, ML; Skeens, M; Steinbach, WJ; Sung, L; Villaluna, D; Zaoutis, TE | 1 |
Borman, AM; Forgács, L; Jakab, Á; Kovács, R; Majoros, L; Nagy, F; Nyikos, F; Tóth, Z | 1 |
Abdollahi, A; Ahmadikia, K; Alijani, N; Barac, A; Jafari, R; Khodavaisy, S; Mehrparvar, G; Pakdel, F; Rajaeih, S; Rezaie, Y; Salehi, M; Tabari, A | 1 |
Amanati, A; Badiee, P; Ghasemi, F; Haghpanah, S; Hamzavi, SS; Jafarian, H; Nematolahi, S | 1 |
Arendrup, M; Botterel, F; Bourgeois, N; Bouteille, B; Canton, E; Cassaing, S; Dannaoui, E; Dehais, M; Delhaes, L; Dupont, D; Espinel-Ingroff, A; Fekkar, A; Forastiero, A; Fuller, J; Garcia, J; Garcia-Effron, G; Gonzalez, GM; Govender, NP; Guegan, H; Guinea, J; Houzé, S; Lackner, M; Lass-Flörl, C; Magobo, R; Pelaez, T; Sasso, M; Turnidge, J | 1 |
Dong, Y; Liu, Z; Wang, Y; Wang, YF; Xie, J; Yang, Q; Zhang, K | 1 |
Hakki, M; Lewis, JS; Thompson, GR; Wiederhold, NP | 1 |
Amin Shahidi, M; Badiee, P; Ghasemi, F; Hashemi, J; Jafarian, H; Mohammadi, R; Najafzadeh, MJ; Shokohi, T | 1 |
58 review(s) available for triazoles and l 743,872
Article | Year |
---|---|
[Clinical development of antimycotics. Medical challenges].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Excipients; Fungi; Humans; Itraconazole; Lipopeptides; Liposomes; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Voriconazole | 2003 |
[A silver lining on the horizon: new antimycotics].
Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Laboratory evaluation of new antifungal agents against rare and refractory mycoses.
Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
New antifungal drugs and new clinical trials: interpreting results may be difficult.
Topics: Animals; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Data Interpretation, Statistical; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide.
Topics: Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Biguanides; Caspofungin; Child, Preschool; Disinfectants; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Mucormycosis; Osteomyelitis; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2003 |
[New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
Topics: Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Fungi; Glucosyltransferases; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
New antifungal agents.
Topics: Administration, Oral; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Drug Approval; Echinocandins; Humans; Lipopeptides; Macrolides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2003 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.
Topics: Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Humans; Immunocompromised Host; Lipopeptides; Male; Mitosporic Fungi; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2004 |
[New antifungal agents: voriconazole and caspofungin].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
CNS-aspergillosis: are there new treatment options?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[New therapeutical options for pulmonary fungal infections in non-neutropenic ICU-patients].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Fungi; Humans; Intensive Care Units; Lipopeptides; Lung Diseases, Fungal; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2003 |
New options for the treatment of invasive fungal infections.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
[New antifungal agents and bronchopulmonary mycoses].
Topics: Antifungal Agents; Caspofungin; Drug Costs; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2004 |
[Invasive aspergillosis: clinical manifestations and treatment].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Dermatomycoses; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Immunologic Factors; Itraconazole; Lipopeptides; Neuroaspergillosis; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Respiratory Tract Infections; Triazoles; Voriconazole | 2003 |
Use of newer antifungal therapies in clinical practice: what do the data tell us?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Combination antifungal therapy: where are we now, and where are we going?
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Antifungal resistance: the clinical front.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Health Status; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome; Triazoles; United States; Voriconazole | 2004 |
Systemic aspergillosis with predominant genitourinary manifestations in an immunocompetent man: what we can learn from a disastrous follow-up.
Topics: Abscess; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Diseases; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Peptides, Cyclic; Prostatic Diseases; Pyrimidines; Retroperitoneal Space; Triazoles; Voriconazole | 2005 |
A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Female; Heart Transplantation; Humans; Lipopeptides; Mediastinitis; Middle Aged; Peptides, Cyclic; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole | 2005 |
[Update on therapy of invasive mycoses in hematology and oncology].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2005 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Voriconazole: review of a broad spectrum triazole antifungal agent.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2005 |
Antifungal treatment in pediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Humans; Infant; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Triazoles | 2005 |
Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Chemoprevention; Drug Resistance, Fungal; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Peptides, Cyclic; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Cross Infection; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Echinocandins; Food-Drug Interactions; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Liver; Mycoses; Peptides, Cyclic; Polypharmacy; Pyrimidines; Reverse Transcriptase Inhibitors; Triazoles; Voriconazole | 2005 |
Fungal infections in bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Administration Schedule; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Postoperative Complications; Premedication; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
[Efficacies and clinical roles of new antifungal agents].
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
[Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review].
Topics: Amaurosis Fugax; Aneurysm, Infected; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Biomarkers; Caspofungin; Combined Modality Therapy; Echinocandins; Endocarditis; False Negative Reactions; Fatal Outcome; Fungemia; Galactose; Heart Valve Prosthesis Implantation; Humans; Infarction; Kidney; Lipopeptides; Male; Mannans; Mesenteric Arteries; Mesenteric Vascular Occlusion; Middle Aged; Mitral Valve; Peptides, Cyclic; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Renal Artery; Triazoles; Voriconazole | 2007 |
[Addressing the "Hot Spots" in the management of invasive aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Disease Management; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Treatment Outcome; Triazoles | 2007 |
Invasive pulmonary aspergillosis after liver transplantation: rapid and complete response to combined and sequential antifungal therapy.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Immunosuppression Therapy; Lipopeptides; Liver Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography, Thoracic; Tomography, Emission-Computed; Triazoles; Voriconazole | 2008 |
Acute monoblastic leukemia with t(10;11)(p12;q23) presenting with pulmonary involvement: a case report and literature review.
Topics: Adult; Antibiotics, Antineoplastic; Antifungal Agents; Antimetabolites, Antineoplastic; Aspergillosis, Allergic Bronchopulmonary; Bronchoalveolar Lavage; Caspofungin; Cytarabine; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Monocytic, Acute; Lipopeptides; Lung Neoplasms; Male; Pyrimidines; Thailand; Triazoles; Voriconazole | 2008 |
Treatment of invasive candidal infections: systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Trends in development of new antifungal agents in Japan].
Topics: Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Discovery; Echinocandins; Humans; Japan; Lipopeptides; Mycoses; Triazoles | 2008 |
Diagnosis and treatment of aspergillosis in children.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Echinocandins; Fungal Vaccines; Genomics; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2009 |
Invasive Aspergillus fumigatus infection after Plasmodium falciparum malaria in an immuno-competent host: case report and review of literature.
Topics: Antifungal Agents; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Malaria, Falciparum; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2009 |
Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Debridement; Echinocandins; Humans; Hyperbaric Oxygenation; Immunologic Factors; Lipopeptides; Oxygen; Triazoles; Zygomycosis | 2009 |
Primary antifungal prophylaxis in acute myeloblastic leukemia and myelodysplastic syndrome--still an open question?
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Resistance, Fungal; Echinocandins; Fever; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Medical Oncology; Mycoses; Myelodysplastic Syndromes; Triazoles | 2010 |
Modern antifungal therapy for neutropenic fever.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2006 |
Traditional and emerging antifungal therapies.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2010 |
Aspergillus fumigatus joint infection: a review.
Topics: Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Caspofungin; Combined Modality Therapy; Drainage; Echinocandins; Female; Humans; Immunocompromised Host; Lipopeptides; Middle Aged; Pyrimidines; Sacroiliac Joint; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature.
Topics: Aged; Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Female; Geotrichosis; Geotrichum; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2011 |
Invasive aspergillosis in patients with liver disease.
Topics: Aged; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Liver Diseases; Lung; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2011 |
[Combination therapy for invasive aspergillosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Echinocandins; Forecasting; Fungemia; Guinea Pigs; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Meningitis, Fungal; Micafungin; Mice; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles | 2011 |
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Therapy, Combination; Echinocandins; Evidence-Based Medicine; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2011 |
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Endophthalmitis caused by Phialophora verrucosa: a case report and literature review of Phialophora ocular infections.
Topics: Aged; Amphotericin B; Antifungal Agents; Caspofungin; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Glaucoma; Humans; Hypertension; Intravitreal Injections; Lipopeptides; Male; Phialophora; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2012 |
Diagnosis of airway-invasive pulmonary aspergillosis by tree-in-bud sign in an immunocompetent patient: case report and literature review.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biopsy; Bronchiolitis; Bronchoscopy; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Humans; Immunocompetence; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Lung; Male; Pyrimidines; Sputum; Tomography, X-Ray Computed; Triazoles; Tuberculosis, Pulmonary; Voriconazole; Young Adult | 2013 |
Combination antifungal therapy for invasive fungal infections in children and adults.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Child; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Pyrimidines; Triazoles; Voriconazole | 2013 |
Dosing of antifungal agents in obese people.
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Obesity; Pyridines; Triazoles | 2016 |
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Debridement; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Triazoles; Virulence | 2016 |
Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Cunninghamella; Debridement; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hemochromatosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyridines; Treatment Outcome; Triazoles | 2019 |
Therapeutic tools for oral candidiasis: Current and new antifungal drugs.
Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis, Oral; Caspofungin; Clotrimazole; Databases, Factual; Drug Interactions; Echinocandins; Fluconazole; Humans; Miconazole; Nitriles; Nystatin; Pyridines; Triazoles | 2019 |
New Perspectives on Antimicrobial Agents: Isavuconazole.
Topics: Antifungal Agents; Candidiasis, Invasive; Caspofungin; Fungi; Humans; Invasive Fungal Infections; Nitriles; Pyridines; Triazoles; Voriconazole | 2022 |
8 trial(s) available for triazoles and l 743,872
Article | Year |
---|---|
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole; Young Adult | 2010 |
Lack of pharmacokinetic drug interaction between oral posaconazole and caspofungin or micafungin.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Area Under Curve; Caspofungin; Drug Interactions; Echinocandins; Female; Humans; Infusions, Intravenous; Lipopeptides; Male; Micafungin; Triazoles; Young Adult | 2011 |
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia.
Topics: Antifungal Agents; Australia; Caspofungin; Echinocandins; Economics, Pharmaceutical; Fever; Humans; Lipopeptides; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2012 |
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.
Topics: Adult; Aged; Candida; Candidemia; Candidiasis, Invasive; Caspofungin; Female; Humans; Male; Middle Aged; Nitriles; Pyridines; Treatment Outcome; Triazoles | 2019 |
A Randomized Trial of Caspofungin vs Triazoles Prophylaxis for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplant.
Topics: Adolescent; Adult; Antifungal Agents; Caspofungin; Child; Child, Preschool; Hematopoietic Stem Cell Transplantation; Humans; Infant; Invasive Fungal Infections; Mycoses; Triazoles; Young Adult | 2021 |
286 other study(ies) available for triazoles and l 743,872
Article | Year |
---|---|
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Culture Media; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Structure-Activity Relationship; Triazoles; Yeasts | 1998 |
[Antifungal drugs: the new frontier].
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole | 1998 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Guinea Pigs; Lipopeptides; Male; Organ Culture Techniques; Peptides; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2002 |
In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Interactions; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2002 |
Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility test
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Quality Control; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2002 |
New drugs, old drugs - dear drugs, cheap drugs.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Marrow Transplantation; Caspofungin; Cyclosporine; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole | 2002 |
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2003 |
Comment: caspofungin acetate for treatment of invasive fungal infections.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Guinea Pigs; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus.
Topics: Aspergillus fumigatus; Caspofungin; Drug Interactions; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Triazoles | 2003 |
Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antigen Presentation; Aspergillosis; Aspergillus fumigatus; Caspofungin; Dendritic Cells; Echinocandins; Lipopeptides; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptides; Peptides, Cyclic; Pyrimidines; Specific Pathogen-Free Organisms; T-Lymphocytes; Triazoles; Voriconazole | 2003 |
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Penicillium; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2003 |
Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy.
Topics: Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Brain Abscess; Brain Diseases; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Immunologic Deficiency Syndromes; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Leukemia, Myelomonocytic, Acute; Lipopeptides; Male; Middle Aged; Peptides; Peptides, Cyclic; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Colorimetry; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Reproducibility of Results; Sensitivity and Specificity; Triazoles | 2004 |
[symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2004 |
Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.
Topics: Adolescent; Amphotericin B; Bone Marrow Transplantation; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Humans; Leukemia; Lipopeptides; Liposomes; Male; Peptides; Peptides, Cyclic; Pneumonia; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2004 |
Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lipopeptides; Lung; Middle Aged; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillus fumigatus; Calcineurin; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Drug Interactions; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2004 |
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Child; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Liposomes; Male; Mycoses; Myelodysplastic Syndromes; Peptides; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease.
Topics: Adolescent; Amphotericin B; Aspergillosis; Aspergillus nidulans; Caspofungin; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Granulomatous Disease, Chronic; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Risk Assessment; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Liver Transplantation; Peptides; Peptides, Cyclic; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China.
Topics: Animals; Antifungal Agents; Caspofungin; China; Columbidae; Cryptococcosis; Cryptococcus neoformans; Drug Interactions; Echinocandins; Feces; Flucytosine; Humans; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Thiazoles; Triazoles | 2004 |
Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Echinocandins; Fatal Outcome; Female; Humans; Kidney Transplantation; Lipopeptides; Lymphoma, Non-Hodgkin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2004 |
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Combination antifungal therapy for invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Combination therapy for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Fluconazole; Hematologic Neoplasms; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus.
Topics: Aminoglycosides; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Interactions; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Polyenes; Triazoles | 2004 |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Echinocandins; Humans; Immunosuppressive Agents; Lipopeptides; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2004 |
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aqueous Humor; Biological Availability; Candidiasis; Caspofungin; Chromatography, High Pressure Liquid; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Female; Fungemia; Humans; Infusions, Intravenous; Injections; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Triazoles; Vitreous Body; Voriconazole | 2005 |
Caspofungin versus liposomal amphotericin B for empirical therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Triazoles | 2005 |
Caspofungin versus liposomal amphotericin B for empirical therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Infusions, Intravenous; Lipopeptides; Liposomes; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Caspofungin versus liposomal amphotericin B for empirical therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2005 |
[Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Neoplasms; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2004 |
Successful antifungal combination therapy with voriconazole and caspofungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Child, Preschool; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2005 |
Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Male; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2005 |
Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Granulocytes; Humans; Leukocyte Transfusion; Lipopeptides; Magnetic Resonance Imaging; Male; Melphalan; Middle Aged; Multiple Myeloma; Necrosis; Peptides, Cyclic; Pyrimidines; Radiography; Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2005 |
Combination antifungal therapy for invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes.
Topics: Absidia; Antifungal Agents; Caspofungin; Culture Media; Cunninghamella; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Mucor; Mucorales; Peptides, Cyclic; Pyrimidines; Rhizopus; Triazoles; Voriconazole | 2005 |
In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
Topics: Antifungal Agents; Candida glabrata; Candidiasis, Oral; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Triazoles | 2005 |
Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Echinocandins; Guinea Pigs; Kidney; Lipopeptides; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2005 |
Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Cataract Extraction; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Lens Implantation, Intraocular; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2005 |
Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry.
Topics: Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Flow Cytometry; Fluorescent Dyes; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Propidium; Pyrimidines; Triazoles; Voriconazole | 2005 |
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Austria; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Genes, Fungal; Hematologic Neoplasms; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Peptides, Cyclic; Prevalence; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Advances in antifungal therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole | 2005 |
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole | 2005 |
Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Magnetic Resonance Imaging; Mediastinal Diseases; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Recurrence; Thoracoscopy; Triazoles; Voriconazole | 2005 |
Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia.
Topics: AC133 Antigen; Amphotericin B; Antifungal Agents; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Caspofungin; Child; Combined Modality Therapy; Contraindications; Dexamethasone; Drug Therapy, Combination; Echinocandins; Glycoproteins; Humans; Immunomagnetic Separation; Lipopeptides; Male; Mercaptopurine; Methotrexate; Peptides; Peptides, Cyclic; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Vincristine; Voriconazole; Zygomycosis | 2007 |
Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Central Nervous System Fungal Infections; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Lipopeptides; Lipoproteins; Liposomes; Micafungin; Mice; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Intensive Care Units; Lipopeptides; Peptides, Cyclic; Pyrimidines; Thrombophlebitis; Triazoles; Vena Cava, Inferior; Voriconazole | 2005 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Biomass; Caspofungin; Cryptococcus neoformans; Dose-Response Relationship, Drug; Echinocandins; Enzyme-Linked Immunosorbent Assay; Fluconazole; Formazans; Lipopeptides; Melanins; Microbial Sensitivity Tests; Microscopy, Confocal; Peptides, Cyclic; Plankton; Pyrimidines; Triazoles; Voriconazole | 2006 |
Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole.
Topics: Antifungal Agents; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Discitis; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Middle Aged; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Peptides, Cyclic; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2006 |
Unclear fever 7 weeks after renal transplantation in a 56-year-old patient.
Topics: Abscess; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biopsy, Fine-Needle; Caspofungin; Contraindications; Cyclosporine; Delayed Graft Function; Drug Interactions; Echinocandins; Fever of Unknown Origin; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lipopeptides; Male; Middle Aged; Mycophenolic Acid; Peptides, Cyclic; Postoperative Complications; Prednisone; Pyrimidines; Radionuclide Imaging; Stenotrophomonas maltophilia; Surgical Wound Infection; Thyroiditis; Triazoles; Ultrasonography; Voriconazole | 2006 |
Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Drug Interactions; Drug Therapy, Combination; Echinocandins; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Peptides, Cyclic; Triazoles | 2006 |
A case of pulmonary aspergillosis with lack of response to caspofungin.
Topics: Acute Disease; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Diseases; Candidiasis; Caspofungin; Combined Modality Therapy; Contraindications; Echinocandins; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid; Lipopeptides; Lung Diseases, Fungal; Middle Aged; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole | 2006 |
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
Topics: Adult; Aged; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2006 |
Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman.
Topics: Adult; Amphotericin B; Antifungal Agents; Arthritis; Aspergillus fumigatus; Brain; Brain Abscess; Caspofungin; Chromatography, Liquid; Echinocandins; Female; Humans; Lipopeptides; Magnetic Resonance Imaging; Mass Spectrometry; Neuroaspergillosis; Paranasal Sinus Diseases; Peptides, Cyclic; Pyrimidines; Staphylococcus aureus; Triazoles; Voriconazole | 2006 |
Disseminated invasive aspergillosis in a patient with acute leukaemia.
Topics: Acute Kidney Injury; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bacteremia; Caspofungin; Chlamydophila Infections; Chlamydophila pneumoniae; Doxorubicin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Liposomes; Lung Diseases, Fungal; Medical Futility; Methotrexate; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pneumonia, Bacterial; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Streptococcal Infections; Triazoles; Vincristine; Voriconazole | 2006 |
Antifungal effects on metabolite profiles of medically important yeast species measured by nuclear magnetic resonance spectroscopy.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Caspofungin; Echinocandins; Indicator Dilution Techniques; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2006 |
Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Benzoates; Brain Stem; Caspofungin; Cavernous Sinus; Central Nervous System Fungal Infections; Deferasirox; Diabetic Ketoacidosis; Drug Therapy, Combination; Echinocandins; Humans; Iron Chelating Agents; Lipopeptides; Magnetic Resonance Imaging; Male; Mucormycosis; Nose Diseases; Peptides, Cyclic; Salvage Therapy; Triazoles | 2006 |
Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Male; Middle Aged; Panophthalmitis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
Topics: Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Global Health; Humans; Lipopeptides; Peptides, Cyclic; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2006 |
Multi-azole resistance in Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2006 |
Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Drug Antagonism; Drug Combinations; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2006 |
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Brain; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluorescence Resonance Energy Transfer; Immunocompromised Host; Immunosuppression Therapy; Itraconazole; Kidney; Lipopeptides; Liver; Lung; Male; Mice; Neutropenia; Nitriles; Peptides, Cyclic; Polymerase Chain Reaction; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2006 |
In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.
Topics: Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
Topics: Air Microbiology; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Cross Infection; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole; Water Microbiology | 2007 |
Unexplained increase in Paecilomyces variotii blood culture isolates in the UK.
Topics: Amphotericin B; Antifungal Agents; Blood; Caspofungin; Diagnosis, Differential; Echinocandins; Equipment Contamination; False Positive Reactions; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Paecilomyces; Peptides, Cyclic; Pyrimidines; Species Specificity; Triazoles; United Kingdom; Voriconazole | 2006 |
Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, cas
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
Caspofungin for the treatment of azole resistant candidemia in a premature infant.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Microbial; Echinocandins; Humans; Hypercalcemia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Male; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Body Weight; Caspofungin; Cost-Benefit Analysis; Echinocandins; Health Care Costs; Humans; Injections, Intravenous; Lipopeptides; Multivariate Analysis; Peptides, Cyclic; Pyrimidines; Severity of Illness Index; Spain; Treatment Outcome; Triazoles; Voriconazole | 2007 |
The effects of caspofungin and voriconazole in experimental Candida endophthalmitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Cornea; Disease Models, Animal; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Itraconazole; Lipopeptides; Peptides, Cyclic; Pyrimidines; Rabbits; Triazoles; Voriconazole | 2007 |
Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Culture Media; Disk Diffusion Antimicrobial Tests; Echinocandins; Fungi; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Successful management of Aspergillus liver abscess in a patient with necrotizing fasciitis.
Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Fasciitis, Necrotizing; Female; Humans; Lipopeptides; Liver Abscess; Peptides, Cyclic; Pregnancy; Pyrimidines; Triazoles; Voriconazole | 2007 |
Acquired resistance to echinocandins in Candida albicans: case report and review.
Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genotype; HIV Infections; HIV-1; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2007 |
Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Female; Fusarium; Humans; Lipopeptides; Mycoses; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Diagnostic and therapeutic challenge of Aspergillus flavus scleritis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Substance Abuse, Intravenous; Triazoles; Voriconazole | 2007 |
Secular trends in severe renal failure associated with the use of new antimicrobial agents in critically ill surgical patients.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Caspofungin; Cohort Studies; Critical Illness; Echinocandins; Female; Humans; Intensive Care Units; Linezolid; Lipopeptides; Male; Middle Aged; Oxazolidinones; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cost-Benefit Analysis; Costs and Cost Analysis; Data Interpretation, Statistical; Decision Trees; Drug Combinations; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Models, Economic; Models, Statistical; Netherlands; Pyrimidines; Reproducibility of Results; Survival Analysis; Triazoles; Voriconazole | 2007 |
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Natamycin; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2007 |
Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient.
Topics: Adult; Antifungal Agents; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Male; Mycetoma; Pleurisy; Pyrimidines; Scedosporium; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole | 2008 |
Synergistic effect of posaconazole and caspofungin against clinical zygomycetes.
Topics: Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Fungi; Lipopeptides; Microbial Sensitivity Tests; Triazoles | 2007 |
In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolates.
Topics: Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease.
Topics: Adult; Antifungal Agents; Basidiomycota; Caspofungin; Echinocandins; Granulomatous Disease, Chronic; HMGB1 Protein; Humans; Lipopeptides; Male; Mycoses; Osteomyelitis; Peptides, Cyclic; Pyrimidines; Sacrum; Triazoles; Voriconazole | 2007 |
Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Heart Transplantation; Heart-Assist Devices; Humans; Lipopeptides; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2008 |
Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy.
Topics: Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Colletotrichum; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungi; Fungicides, Industrial; Humans; In Vitro Techniques; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Nystatin; Plant Diseases; Skin; Triazoles | 2007 |
Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Ascomycota; Aspergillus flavus; Caspofungin; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Humans; Lipopeptides; Male; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole | 2007 |
Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole.
Topics: Adult; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Encephalitis; Humans; Lipopeptides; Male; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole | 2007 |
Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin/posaconazole therapy.
Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Triazoles | 2008 |
In vitro activities of voriconazole as a triazole derivative and caspofungin as an echinocandin were compared with those of some antifungal agents against Candida species isolated from clinical specimens.
Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Sputum; Triazoles; Voriconazole | 2007 |
Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Caspofungin; Disease Models, Animal; Echinocandins; Exophiala; Female; Immunocompromised Host; Kidney; Lipopeptides; Mice; Mice, Inbred ICR; Mycoses; Survival Analysis; Triazoles | 2007 |
Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient.
Topics: Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Leukemia, Plasma Cell; Lipopeptides; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole | 2008 |
Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Lipopeptides; Liposomes; Male; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Transplantation, Homologous; Triazoles; Voriconazole | 2007 |
Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2007 |
Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chemotherapy, Adjuvant; Drug Evaluation; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Administration Schedule; Echinocandins; Humans; Kidney; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles | 2008 |
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Pyrimidines; Rhodotorula; Triazoles; Trichosporon; Voriconazole | 2008 |
Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Laboratories; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole | 2008 |
[Antifungal activity of posaconazole and caspofungin in yeast causing invasive fungal infection (2002-2003). E-test system evaluation].
Topics: Antifungal Agents; Candida; Caspofungin; Cryptococcus; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Rhodotorula; Sensitivity and Specificity; Species Specificity; Triazoles | 2008 |
Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Cutaneous, pulmonary and bone aspergillosis in a patient presumed immunocompetent presenting subacute cutaneous lupus erythematosus].
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bone Diseases, Infectious; Caspofungin; Echinocandins; Humans; Lipopeptides; Lung; Lung Diseases, Fungal; Lupus Erythematosus, Systemic; Male; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Successful treatment of disseminated Geotrichum capitatum infection with a combination of caspofungin and voriconazole in an immunocompromised patient.
Topics: Antifungal Agents; Caspofungin; Drug Combinations; Echinocandins; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2008 |
Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin.
Topics: Adolescent; Antifungal Agents; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Hematologic Neoplasms; Humans; Lipopeptides; Male; Mycoses; Neutropenia; Pneumonia; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles; Trichoderma; Voriconazole | 2008 |
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia.
Topics: Adolescent; Aspergillosis; Aspergillus fumigatus; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Thyroid Diseases; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2008 |
Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B.
Topics: Aminoglycosides; Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2008 |
Effective management of pulmonary aspergillosis invading the thoracic spine in a child with high risk ALL requiring allogeneic bone marrow transplantation.
Topics: Adoptive Transfer; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bone Marrow Transplantation; Caspofungin; Child; Echinocandins; Female; Graft vs Host Disease; Granulocytes; Humans; Lipopeptides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography, Thoracic; Spine; Triazoles; Voriconazole | 2008 |
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult | 2008 |
In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Fusarium; Humans; Hyphae; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Tacrolimus; Terbinafine; Triazoles; Voriconazole | 2009 |
Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes.
Topics: Antifungal Agents; Candida glabrata; Caspofungin; Cells, Cultured; Drug Interactions; Echinocandins; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Monocytes; Pyrimidines; Triazoles; Voriconazole | 2008 |
Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation.
Topics: Adult; Antifungal Agents; Caspofungin; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Myocarditis; Pyrimidines; Shock, Cardiogenic; Triazoles; Voriconazole | 2009 |
Alternaria infectoria brain abscess in a child with chronic granulomatous disease.
Topics: Alternaria; Antifungal Agents; Brain; Brain Abscess; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Granulomatous Disease, Chronic; Humans; Lipopeptides; Male; Mycoses; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 5.8S; Seizures; Triazoles; Voriconazole | 2009 |
Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biofilms; Caspofungin; Echinocandins; Formazans; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Mycelium; Oxidation-Reduction; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole | 2008 |
In vitro susceptibility of Pythium insidiosum and a Lagenidium sp to itraconazole, posaconazole, voriconazole, terbinafine, caspofungin, and mefenoxam.
Topics: Alanine; Anti-Infective Agents; Caspofungin; Echinocandins; In Vitro Techniques; Itraconazole; Lagenidium; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Terbinafine; Triazoles; Voriconazole | 2008 |
Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin.
Topics: Administration, Topical; Adult; Aged; Alternaria; Antifungal Agents; Caspofungin; Cataract Extraction; Contact Lenses; Corneal Stroma; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Eye Injuries; Female; Fluconazole; Humans; Injections; Keratitis; Lipopeptides; Male; Medical Records; Middle Aged; Pyrimidines; Steroids; Treatment Outcome; Triazoles; Voriconazole | 2009 |
In vitro activity of caspofungin and voriconazole against uncommon Candida spp.
Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
Topics: Adolescent; Adult; Antifungal Agents; Caspofungin; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Humans; Lipopeptides; Male; Plasma; Pyrimidines; Triazoles; Voriconazole | 2009 |
[Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis].
Topics: Abdomen; Antifungal Agents; Caspofungin; Colonic Neoplasms; Critical Illness; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Laparotomy; Lipopeptides; Middle Aged; Peritonitis; Physical Therapy Modalities; Postoperative Complications; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2009 |
Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Cross Infection; Echinocandins; Fungemia; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Triazoles | 2010 |
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Caspofungin; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Leukoencephalopathy, Progressive Multifocal; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2009 |
The effects of caspofungin and voriconazole in an experimental fungal infection of the ear due to Aspergillus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cyclophosphamide; Disease Models, Animal; Echinocandins; Immunocompromised Host; Immunosuppressive Agents; Lipopeptides; Otitis Media; Pyrimidines; Rabbits; Triamcinolone Acetonide; Triazoles; Voriconazole | 2009 |
[Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis].
Topics: Amphotericin B; Antifungal Agents; Bioprosthesis; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Heart Valve Prosthesis; Humans; Lipopeptides; Liposomes; Male; Middle Aged; Photosensitivity Disorders; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole | 2010 |
Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Infant; Infant, Newborn; Lipopeptides; Male; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Salvage Therapy; Triazoles; Voriconazole | 2009 |
Infections caused by Candida krusei in five transplant and two surgical patients.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Caspofungin; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Fungal; Echinocandins; Female; Genotype; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycological Typing Techniques; Organ Transplantation; Postoperative Complications; Pyrimidines; Random Amplified Polymorphic DNA Technique; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.
Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Female; Humans; Lipopeptides; Male; Middle Aged; Pneumonectomy; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia.
Topics: Acute Disease; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus; Caspofungin; Combined Modality Therapy; Echinocandins; Humans; Hyphae; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Leukemia, B-Cell; Lipopeptides; Male; Middle Aged; Neutropenia; Spleen; Splenectomy; Splenic Diseases; Triazoles | 2010 |
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2009 |
Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis.
Topics: Antifungal Agents; Caspofungin; Echinocandins; Endophthalmitis; Fusarium; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Caspofungin; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungemia; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycological Typing Techniques; Polyenes; Population Surveillance; Prevalence; Triazoles | 2010 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts | 2010 |
[Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus flavus; Caspofungin; Chemotherapy, Adjuvant; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Injections, Intraventricular; Lipopeptides; Male; Neuroaspergillosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2009 |
Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Caspofungin; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2010 |
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Prospective Studies; Pyrimidines; Registries; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cervical Vertebrae; Drainage; Echinocandins; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Itraconazole; Lipopeptides; Male; Osteomyelitis; Pyrimidines; Saudi Arabia; Thoracic Vertebrae; Treatment Outcome; Triazoles; Voriconazole | 2010 |
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Lipopeptides; Male; Mycoses; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Prevalence; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2010 |
In vitro activity of antifungal combinations against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Austria; Biofilms; Candida albicans; Candidiasis; Caspofungin; Drug Synergism; Echinocandins; Fungemia; Humans; Intensive Care Units; Lipopeptides; Microbial Sensitivity Tests; Triazoles | 2010 |
Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.
Topics: Adolescent; Adult; Aged; Air Pollutants; Caspofungin; Cohort Studies; Construction Materials; Echinocandins; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2010 |
The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Hyphae; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Spores, Fungal; Tetrazolium Salts; Triazoles; Voriconazole | 2010 |
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Successful triple combination therapy of disseminated absidia corymbifera infection in an adolescent with osteosarcoma.
Topics: Absidia; Adolescent; Amphotericin B; Antineoplastic Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Femoral Neoplasms; Humans; Lipopeptides; Mucormycosis; Opportunistic Infections; Osteosarcoma; Triazoles | 2010 |
Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp.
Topics: Adult; Antifungal Agents; Caspofungin; Cells, Cultured; Cunninghamella; Echinocandins; Enzyme-Linked Immunosorbent Assay; Humans; Interleukin-6; Interleukin-8; Lipopeptides; Microbial Viability; Neutrophils; Pyrimidines; Rhizopus; Tetrazolium Salts; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole | 2010 |
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillus; Caspofungin; Cystic Fibrosis; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.
Topics: Antifungal Agents; Candida glabrata; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Endpoint Determination; Fluconazole; Itraconazole; Lipopeptides; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2010 |
In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2010 |
Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Brain; Caspofungin; Chemoprevention; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Lung Transplantation; Magnetic Resonance Imaging; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Naphthalenes; Pseudallescheria; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 28S; Scedosporium; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2010 |
Chronic necrotizing and allergic bronchopulmonary aspergillosis in an asthmatic patient--a therapeutic challenge.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Asthma; Bronchoscopy; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Prognosis; Pyrimidines; Radiography, Thoracic; Recurrence; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Cohort Studies; Echinocandins; Female; Hospital Costs; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Length of Stay; Lipopeptides; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole | 2011 |
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia.
Topics: Abscess; Antifungal Agents; Caspofungin; Echinocandins; Female; Forearm; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lipopeptides; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole.
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Caspofungin; Corneal Ulcer; Drug Resistance, Fungal; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2010 |
Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Caspofungin; CD11b Antigen; Cells, Cultured; Echinocandins; Gene Expression; Gene Expression Profiling; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Interleukin-8; Lipopeptides; Neutrophils; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptors; Triazoles; Up-Regulation; Voriconazole | 2010 |
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Guideline Adherence; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole | 2010 |
Catheter-associated aspergillosis of the chest wall following allogeneic hematopoietic stem cell transplantation.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Catheters; Child, Preschool; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Pyrimidines; Thoracic Wall; Transplantation, Homologous; Triazoles; Voriconazole | 2011 |
Aspergillus thyroiditis in a renal transplant recipient mimicking subacute thyroiditis.
Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Transplantation; Lipopeptides; Pyrimidines; Thyroid Gland; Thyroiditis; Triazoles; Voriconazole | 2011 |
Successful treatment of sellar aspergillus abscess.
Topics: Aged; Antifungal Agents; Brain Abscess; Caspofungin; Diagnosis, Differential; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Neuroaspergillosis; Neurosurgical Procedures; Pituitary Diseases; Pituitary Neoplasms; Pyrimidines; Triazoles; Voriconazole | 2010 |
In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Cunninghamella; Diabetes Mellitus, Experimental; Echinocandins; Itraconazole; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2010 |
Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspo
Topics: Anidulafungin; Antifungal Agents; Blood Chemical Analysis; Caspofungin; Chromatography, Liquid; Echinocandins; Humans; Itraconazole; Lipopeptides; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2010 |
Pulmonary aspergillosis in a non-neutropenic critical patient.
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Burns, Inhalation; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Humans; Hydrogen Sulfide; Intensive Care Units; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2010 |
In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Triazoles; Young Adult | 2011 |
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Drug Administration Routes; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Tunisia; Voriconazole | 2011 |
[Fatal outcome of invasive tracheal aspergillosis].
Topics: Antifungal Agents; Bronchi; Carotid Artery, External; Caspofungin; Contrast Media; Echinocandins; Fatal Outcome; Hemoptysis; Humans; Image Processing, Computer-Assisted; Iohexol; Lipopeptides; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, Spiral Computed; Trachea; Tracheal Diseases; Triazoles; Voriconazole; Young Adult | 2011 |
Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis.
Topics: Abscess; Adolescent; Adult; Antifungal Agents; Azoles; Caspofungin; Chemoprevention; DNA, Fungal; DNA, Ribosomal Spacer; Echinocandins; Eurotiales; Fatal Outcome; Female; Granulomatous Disease, Chronic; Histocytochemistry; Humans; Interferon-gamma; Lipopeptides; Male; Microscopy; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles | 2011 |
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Drug Combinations; Echinocandins; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Tetrazolium Salts; Time Factors; Triazoles; Voriconazole | 2011 |
In vitro effectiveness of antifungal lock solutions on catheters infected with Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Colony Count, Microbial; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Triazoles | 2011 |
Antifungal use in hospitalized adults in U.S. academic health centers.
Topics: Academic Medical Centers; Adult; Antifungal Agents; Azoles; Caspofungin; Echinocandins; Humans; Lipopeptides; Multivariate Analysis; Practice Patterns, Physicians'; Pyrimidines; Regression Analysis; Triazoles; United States; Voriconazole | 2011 |
Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.
Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Plankton; Pyrimidines; Triazoles; Voriconazole | 2011 |
Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematology; Hospital Costs; Humans; Length of Stay; Lipopeptides; Male; Middle Aged; Models, Economic; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp.
Topics: Antifungal Agents; Automation; Candida; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Triazoles; United States | 2011 |
Treatment of Alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole.
Topics: Administration, Oral; Administration, Topical; Aged; Alternaria; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Injections, Intraocular; Keratitis; Lipopeptides; Pyrimidines; Triazoles; Voriconazole | 2011 |
Scopulariopsis brevicaulis abscess in a child treated for myeloblastic leukaemia.
Topics: Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Humans; Infant; Leukemia, Myeloid, Acute; Lipopeptides; Lung Abscess; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2011 |
Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Deoxycholic Acid; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Mice; Mice, Inbred DBA; Pyrimidines; Triazoles; Voriconazole | 2011 |
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Ascomycota; Caspofungin; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Fungemia; Heart Transplantation; Histocytochemistry; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Male; Microscopy; Molecular Sequence Data; Mycoses; Pleura; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Eye Infections, Fungal; Fungi; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
An accidental mass.
Topics: Accidents, Traffic; Adult; Aspergillus flavus; Caspofungin; Combined Modality Therapy; Coronary Thrombosis; Diagnosis, Differential; Disease Progression; Echinocandins; Echocardiography; Echocardiography, Transesophageal; Embolism; Emergency Service, Hospital; Endocarditis; Female; Fractures, Bone; Humans; Incidental Findings; Invasive Pulmonary Aspergillosis; Lipopeptides; Mediastinal Diseases; Pelvic Bones; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method.
Topics: Antifungal Agents; Candida; Caspofungin; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
The reversed halo sign as the initial radiographic sign of pulmonary zygomycosis.
Topics: Amphotericin B; Antifungal Agents; Benzoates; Caspofungin; Deferasirox; Echinocandins; Fatal Outcome; Female; Humans; Iron Chelating Agents; Lipopeptides; Lung; Lung Diseases, Fungal; Middle Aged; Mucormycosis; Rhizopus; Stem Cell Transplantation; Tomography, X-Ray Computed; Triazoles | 2012 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases.
Topics: Adult; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fluconazole; Humans; Lipopeptides; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Trichosporonosis; Voriconazole; Young Adult | 2011 |
Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cerebrum; Echinocandins; Humans; Larynx; Lipopeptides; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Paranasal Sinuses; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Sweden; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Female; Heart Defects, Congenital; Humans; Immunocompromised Host; Lipopeptides; Mediastinitis; Mycoses; Peritoneal Dialysis; Peritonitis; Postoperative Complications; Pyrimidines; Spleen; Triazoles; Trichoderma; Voriconazole | 2011 |
Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2012 |
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
Topics: Aminopyridines; Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Echinocandins; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cross Infection; Echinocandins; Female; Fluconazole; Hospitals; Humans; Italy; Itraconazole; Lipopeptides; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Biomarkers; Caspofungin; Disease Models, Animal; DNA, Fungal; Early Diagnosis; Echinocandins; Galactose; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Lipopeptides; Mannans; Microbiological Techniques; Mycological Typing Techniques; Predictive Value of Tests; Rats; Real-Time Polymerase Chain Reaction; Time Factors; Triazoles | 2012 |
Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Diffusion Chambers, Culture; Echinocandins; Galactose; Humans; Lipopeptides; Mannans; Microbial Sensitivity Tests; Pulsatile Flow; Pyrimidines; Species Specificity; Spores, Fungal; Triazoles; Voriconazole | 2012 |
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2012 |
Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit.
Topics: Aged, 80 and over; Air Microbiology; Antifungal Agents; Aspergillosis; Aspergillus; Cardiac Surgical Procedures; Caspofungin; Coronary Care Units; Disease Outbreaks; Echinocandins; Female; Humans; Incidence; Lipopeptides; Male; Middle Aged; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole | 2012 |
[Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Peptides of the constant region of antibodies display fungicidal activity.
Topics: Animals; Antibodies; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Cryptococcus neoformans; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Erythrocytes; Female; Hemolysis; Humans; Immunoglobulin A; Immunoglobulin Constant Regions; Immunoglobulin G; Immunoglobulin M; Lipopeptides; Malassezia; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides; Triazoles | 2012 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole | 2012 |
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Ambulatory therapy of aspergillosis in hematological and oncological patients].
Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole | 2012 |
Pseudomembranous necrotizing tracheobronchial aspergillosis: an analysis of 16 cases.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Bronchoscopy; Caspofungin; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients.
Topics: Adult; Antifungal Agents; Biomarkers; Bronchoalveolar Lavage Fluid; Caspofungin; Drug Therapy, Combination; Echinocandins; Galactose; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Mannans; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Transplantation; Triazoles; Voriconazole | 2012 |
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Fatal bronchial invasion of Scopulariopsis brevicaulis in an acute monocytic leukemia patient.
Topics: Adult; Amphotericin B; Bronchi; Caspofungin; DNA, Fungal; DNA, Ribosomal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Genes, rRNA; Histocytochemistry; Humans; Leukemia, Monocytic, Acute; Lipopeptides; Lung; Lung Diseases, Fungal; Molecular Sequence Data; Pyrimidines; Radiography, Thoracic; RNA, Fungal; RNA, Ribosomal, 18S; Scopulariopsis; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole | 2012 |
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Cohort Studies; Demography; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Length of Stay; Lipopeptides; Lung; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Time Factors; Triazoles; Voriconazole | 2013 |
Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cyclophosphamide; Deoxycholic Acid; Drug Combinations; Echinocandins; Endothelial Cells; Heart; Immunosuppression Therapy; Intercellular Adhesion Molecule-1; Kidney; Lipopeptides; Lung; Male; Mice; Nephrosis; Neuroaspergillosis; P-Selectin; Pyrimidines; Triazoles; Voriconazole | 2012 |
Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Caspofungin; CD4 Lymphocyte Count; Echinocandins; Female; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; L-Lactate Dehydrogenase; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2013 |
[Fungal infection secondary to treatment of Escherichia coli in a critically ill patient].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillus; Candida; Candidiasis; Caspofungin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Echinocandins; Escherichia coli; Fungemia; Humans; Lipopeptides; Male; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2012 |
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Echinocandins; Female; Fluconazole; HIV Infections; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Mouth; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Pyrimidines; Triazoles; Voriconazole | 2012 |
Better hospital nutrition needed to prevent and treat Aspergillus infections.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Male; Pyrimidines; Triazoles; Voriconazole | 2013 |
Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caspofungin; Colony Count, Microbial; Dentures; Diabetes Complications; Echinocandins; Female; Fluconazole; Humans; Hypertension; Kidney Failure, Chronic; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Mycology; Nystatin; Phenotype; Pyrimidines; Renal Dialysis; Time Factors; Triazoles; Voriconazole | 2013 |
Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Caspofungin; Combined Modality Therapy; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Point Mutation; Postoperative Complications; Pulmonary Aspergillosis; Recurrence; Spain; Species Specificity; Transplantation Conditioning; Transplantation, Homologous; Triazoles | 2013 |
Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Biofilms; Caspofungin; Colorimetry; Coloring Agents; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole | 2012 |
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Cyclosporine; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2012 |
Voriconazole stability in cement spacers.
Topics: Antifungal Agents; Arthroplasty, Replacement, Hip; Biofilms; Bone Cements; Candida glabrata; Candidiasis; Caspofungin; Device Removal; Dose-Response Relationship, Drug; Drug Implants; Drug Stability; Drug Therapy, Combination; Echinocandins; Hip Prosthesis; Humans; Infusions, Intravenous; Lipopeptides; Male; Middle Aged; Prostheses and Implants; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Disseminated infection due to Geotrichum capitatum].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Geotrichosis; Geotrichum; Granuloma; Hepatitis; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lipopeptides; Male; Neutropenia; Opportunistic Infections; Sepsis; Triazoles | 2012 |
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Exophiala; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii.
Topics: Antifungal Agents; Caspofungin; Ciprofloxacin; Coccidioides; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Histoplasma; Lipopeptides; Microbial Sensitivity Tests; Mycelium; Pyrimidines; Triazoles; Voriconazole | 2013 |
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Dose-Response Relationship, Drug; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Triazoles; Voriconazole | 2013 |
Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series.
Topics: Adolescent; Antifungal Agents; Caspofungin; Child; Child, Preschool; Coccidioidomycosis; Echinocandins; Female; Humans; Infant; Lipopeptides; Male; Pyrimidines; Retrospective Studies; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Elements of style in managing coccidioidomycosis.
Topics: Antifungal Agents; Caspofungin; Coccidioidomycosis; Echinocandins; Female; Humans; Lipopeptides; Male; Pyrimidines; Triazoles; Voriconazole | 2013 |
Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans.
Topics: Animals; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Ergosterol; Lipopeptides; Male; Mice; Molecular Sequence Data; Mutation; Sequence Homology, Nucleic Acid; Tacrolimus; Triazoles | 2013 |
Drug combinations against Mucor irregularis in vitro.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mucor; Mucormycosis; Naphthalenes; Terbinafine; Triazoles | 2013 |
[Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient].
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Caspofungin; Echinocandins; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lung; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolates.
Topics: Animals; Antifungal Agents; Area Under Curve; Aspergillus fumigatus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Mice; Microbial Sensitivity Tests; Spores, Fungal; Triazoles | 2013 |
Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.
Topics: Acremonium; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2014 |
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida albicans; Candidiasis; Caspofungin; Cefoperazone; Drug Interactions; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyrimidines; Sulbactam; Triazoles; Voriconazole | 2014 |
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2013 |
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
[Three cases of fungemia caused by Blastoschizomyces capitatus].
Topics: Adult; Amphotericin B; Antifungal Agents; Caspofungin; Child; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Saccharomycetales; Triazoles; Voriconazole; Young Adult | 2013 |
In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole | 2013 |
Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species.
Topics: Animals; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Caspofungin; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Galactose; Humans; Lipopeptides; Male; Mannans; Microbial Sensitivity Tests; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Caspofungin; Child; Drug Approval; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Off-Label Use; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole; Young Adult | 2014 |
Antibiotics sensitivity of Candida clinical and food-borne isolates.
Topics: Candida; Caspofungin; Drug Resistance, Bacterial; Echinocandins; Fluconazole; Food Microbiology; Foodborne Diseases; Humans; Lipopeptides; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2013 |
Immunomodulatory effects of voriconazole and caspofungin on human peripheral blood mononuclear cells stimulated by Candida albicans and Candida krusei.
Topics: Adult; Antifungal Agents; Candida albicans; Caspofungin; Cell Proliferation; Cells, Cultured; Echinocandins; Humans; Immunologic Factors; Leukocytes, Mononuclear; Lipopeptides; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
A high-definition view of endogenous fungal endophthalmitis.
Topics: Antifungal Agents; Caspofungin; Echinocandins; Endophthalmitis; Fundus Oculi; Humans; Lipopeptides; Male; Middle Aged; Ophthalmoscopy; Photography; Pyrimidines; Tomography, Optical Coherence; Triazoles; Voriconazole | 2014 |
The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cyclosporine; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2014 |
Invasive cardiac aspergillosis after orthotopic liver transplantation.
Topics: Acute Disease; Caspofungin; Drug Therapy, Combination; Echinocandins; Echocardiography, Transesophageal; Hepatitis B; Humans; Lipopeptides; Liver Failure; Liver Transplantation; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Opportunistic Infections; Postoperative Complications; Pulmonary Aspergillosis; Triazoles | 2014 |
Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Benzoates; Caspofungin; Deferasirox; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mucormycosis; Neutropenia; Rhizopus; Treatment Outcome; Triazoles | 2014 |
The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungal Proteins; Lipopeptides; Tandem Repeat Sequences; Triazoles | 2015 |
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole | 2015 |
In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.
Topics: Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Scopulariopsis; Terbinafine; Triazoles | 2015 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
Topics: Administration, Oral; Adult; Aged; Allografts; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cause of Death; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Lipopeptides; Male; Medication Adherence; Middle Aged; Mycoses; Neutropenia; Patient Compliance; Premedication; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Transplantation Conditioning; Treatment Failure; Triazoles; Young Adult | 2015 |
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Environmental Microbiology; Humans; Iran; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Opportunistic Infections; Triazoles; Voriconazole | 2016 |
In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Benzoxazoles; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Fungal Proteins; Gene Expression; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; TOR Serine-Threonine Kinases; Triazoles; Voriconazole | 2016 |
[NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES].
Topics: Antifungal Agents; Caspofungin; Drug Therapy; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2015 |
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole | 2016 |
Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient.
Topics: Anemia, Aplastic; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Central Nervous System; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrocephalus; Immunocompromised Host; Immunosuppression Therapy; Laminectomy; Lipopeptides; Magnetic Resonance Imaging; Opportunistic Infections; Recurrence; Transplantation, Autologous; Treatment Outcome; Triazoles; Trichosporon; Trichosporonosis; Ventriculoperitoneal Shunt; Voriconazole | 2016 |
Tintelnotia, a new genus in Phaeosphaeriaceae harbouring agents of cornea and nail infections in humans.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Cornea; Echinocandins; Eye Infections, Fungal; Female; Humans; Itraconazole; Keratitis; Lipopeptides; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Phylogeny; Terbinafine; Triazoles; Voriconazole | 2017 |
Epidemiological investigation of Candida species causing bloodstream infection in paediatric small bowel transplant recipients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Humans; Intestine, Small; Itraconazole; Lipopeptides; Male; Multilocus Sequence Typing; Sequence Analysis, DNA; Transplant Recipients; Triazoles; Young Adult | 2017 |
Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
Topics: Antifungal Agents; Ascomycota; Caspofungin; Dihydroorotate Dehydrogenase; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Oxidoreductases Acting on CH-CH Group Donors; Scedosporium; Triazoles; Voriconazole | 2017 |
Changing epidemiology of candidaemia in Australia.
Topics: Anidulafungin; Antifungal Agents; Australia; Azoles; Candida; Candida glabrata; Candida tropicalis; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole | 2017 |
Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a
Topics: Aged; Alleles; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Male; Microbial Sensitivity Tests; Mutation; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Topics: Antifungal Agents; Candida; Caspofungin; Drug Interactions; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Hospitals, University; Humans; Immunocompromised Host; Iran; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2017 |
Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.
Topics: Adolescent; Antifungal Agents; Candida; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Fluconazole; Humans; Kluyveromyces; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Nitriles; Opportunistic Infections; Pichia; Pyridines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole | 2018 |
Liquid chromatography-tandem mass spectrometry for the quantification of moxifloxacin, ciprofloxacin, daptomycin, caspofungin, and isavuconazole in human plasma.
Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Echinocandins; Fluoroquinolones; Humans; Limit of Detection; Lipopeptides; Moxifloxacin; Nitriles; Plasma; Pyridines; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles | 2018 |
Has the Optimal Therapy for Invasive Candidiasis Now Been Defined?
Topics: Candida; Candidemia; Candidiasis, Invasive; Caspofungin; Humans; Nitriles; Pyridines; Triazoles | 2019 |
Impact of Antifungal Compounds on Viability and Anti-
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cell Survival; Deoxycholic Acid; Doxorubicin; Drug Combinations; Fluconazole; Humans; Killer Cells, Natural; Microbial Sensitivity Tests; Polyethylene Glycols; Triazoles; Voriconazole | 2019 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
Topics: Adolescent; Adult; Allografts; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2018 |
Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Caspofungin; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Rhodotorula; Species Specificity; Triazoles; Voriconazole | 2020 |
In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.
Topics: Animals; Antifungal Agents; Biofilms; Candida; Candida auris; Caspofungin; Mice; Microbial Sensitivity Tests; Nitriles; Plankton; Pyridines; Triazoles | 2021 |
Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Coinfection; Comorbidity; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Iran; Male; Middle Aged; Mucormycosis; Respiratory Distress Syndrome; Triazoles; Young Adult | 2021 |
Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antimicrobial Stewardship; Candida; Caspofungin; Child; Child, Preschool; Colony Count, Microbial; Disease Susceptibility; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Triazoles | 2021 |
Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Kluyveromyces; Microbial Sensitivity Tests; Pichia; Saccharomycetales; Triazoles | 2021 |
In vitro synergistic antifungal activities of caspofungin in combination with fluconazole or voriconazole against Candida species determined by the Etest method.
Topics: Antifungal Agents; Candida; Candida glabrata; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2022 |
Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.
Topics: Antifungal Agents; Arthrodermataceae; Caspofungin; Fluconazole; Griseofulvin; Hospitals, University; Humans; Iran; Itraconazole; Terbinafine; Triazoles | 2023 |